Identify Genetic Variations That Affect The Ability of Patients To Metabolize Drugs Through Metabolic Pathways

Clinical trial NCT02525887 · TERMINATED

Trial details

NCT number: NCT02525887
Sponsor: Bracane Company
Status: TERMINATED
Study type: OBSERVATIONAL

Chronic Disease Endocrine System Disease Cardiovascular Disease Respiratory Tract Disease CNS Metabolic Disorders

Start date: 2015-07-01
Primary completion: 2016-01-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.